US2016115250A1PendingUtilityA1

Synthetic Oligosaccharide Subunits Of The PSL Exopolysaccharide Of Pseudomonas Aeruginosa And Uses Thereof

Assignee: MEDIMMUNE LLCPriority: May 14, 2013Filed: May 13, 2014Published: Apr 28, 2016
Est. expiryMay 14, 2033(~6.8 yrs left)· nominal 20-yr term from priority
A61P 37/04A61P 31/04G01N 2500/04G01N 2400/02A61K 47/646A61K 47/643C08B 37/006G01N 33/56911A61K 39/104G01N 2400/38G01N 2333/21C08B 37/0006A61K 2039/6081G01N 33/5308G01N 2400/00C07H 15/04A61K 47/48284A61K 47/4833
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This disclosure relates to synthetic oligosaccharide subunits of the Pseudomonas exosaccharide Psi and uses thereof, e.g., for epitope mapping of anti-Psl antibodies, for identification of anti-Psl antibodies, and for use as vaccines. In one aspect a synthetic oligosaccharide subunit of a Pseudomonas aeruginosa Psl oligosaccharide is provided, comprising the trisaccharide of formula I.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A synthetic oligosaccharide subunit of a  Pseudomonas aeruginosa  Psl oligosaccharide, comprising the trisaccharide of formula I: 
       
         
           
           
               
               
           
         
         wherein R 1  is —OH or 
       
       
         
           
           
               
               
           
         
       
       wherein R 2  is —OH or 
       
         
           
           
               
               
           
         
         wherein R 3  is —OX, where X is hydrogen, an alkyl group, or an aryl group; a linker, wherein the linker can be —O—(CH 2 ) n —NH 2 , —O—(CH 2 ) n —COOH, —O—(CH 2 ) n —N 3 , —O—(CH 2 ) n —S(CH 2 ) m —NH 2 , —O—(CH 2 ) n —S(CH 2 ) m —COOH, —O—(CH 2 ) n —S(CH 2 ) m —N 3 , —O—(CH 2 ) n —SO 2 (CH 2 ) m —NH 2 , —O—(CH 2 ) n —SO 2 (CH 2 ) m —COOH, or —O—(CH 2 ) n —SO 2 (CH 2 ) m —N 3 , wherein n and m are the same or different and are independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; or a linker coupled to a heterologous moiety via conjugation, wherein the heterologous moiety can be a protein, a lipid or a polymer; and 
         wherein the oligosaccharide subunit can be specifically bound by the anti-Psl monoclonal antibody WapR-016, or an antigen binding fragment thereof. 
       
     
     
         2 . The oligosaccharide subunit of  claim 1 , comprising the hexasaccharide: 
       
         
           
           
               
               
           
         
         or the decasaccharide: 
       
       
         
           
           
               
               
           
         
       
     
     
         3 . The oligosaccharide subunit of  claim 1  or  claim 2 , wherein monoclonal antibody WapR-016 comprises VH and VL amino acid sequences of SEQ ID NO:11 and SEQ ID NO:12, respectively. 
     
     
         4 . A synthetic oligosaccharide subunit of a  Pseudomonas aeruginosa  Psl oligosaccharide, comprising the tetrasaccharide of formula II: 
       
         
           
           
               
               
           
         
         wherein R 4  is —OH or 
       
       
         
           
           
               
               
           
         
         wherein R 5  is —OH, 
       
       
         
           
           
               
               
           
         
         wherein R 3  is —OX, where X is hydrogen, an alkyl group, or an aryl group; a linker, wherein the linker can be —O—(CH 2 ) n —NH 2 , —O—(CH 2 ) n —COOH, —O—(CH 2 ) n —N 3 , —O—(CH 2 ) n —S(CH 2 ) m —NH 2 , —O—(CH 2 ) n —S(CH 2 ) m —COOH, —O—(CH 2 ) n —S(CH 2 ) m —N 3 , —O—(CH 2 ) n —SO 2 (CH 2 ) m —NH 2 , —O—(CH 2 ) n —SO 2 (CH 2 ) m —COOH, or —O—(CH 2 ) n —SO 2 (CH 2 ) m —N 3 , where n and m are the same or different and are independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; or a linker coupled to a heterologous moiety via conjugation, wherein the heterologous moiety can be a protein, a lipid or a polymer; and 
         wherein the oligosaccharide subunit can be specifically bound by the anti-Psl monoclonal antibody WapR-001, or an antigen binding fragment thereof. 
       
     
     
         5 . The oligosaccharide subunit of  claim 4 , comprising the tetrasaccharide of: 
       
         
           
           
               
               
           
         
         the pentasaccharide of: 
       
       
         
           
           
               
               
           
         
         the hexasaccharide of: 
       
       
         
           
           
               
               
           
         
         or the decasaccharide of: 
       
       
         
           
           
               
               
           
         
       
     
     
         6 . The oligosaccharide subunit of  claim 4  or  claim 5 , wherein monoclonal antibody WapR-001 comprises VH and VL amino acid sequences of SEQ ID NO:5 and SEQ ID NO:6, respectively. 
     
     
         7 . The oligosaccharide subunit of  claim 1 , wherein anti-Psl monoclonal antibody WapR-016, or an antigen binding fragment thereof cannot specifically bind to the tetrasaccharide of  claim 5  or the pentasaccharide of  claim 5 . 
     
     
         8 . The oligosaccharide subunit of any one of  claims 1  to  7 , which is conjugated to a polypeptide, a lipid, or a polymer. 
     
     
         9 . The oligosaccharide subunit of  claim 8 , wherein the polypeptide is albumin. 
     
     
         10 . The oligosaccharide subunit of  claim 9 , wherein the polypeptide is bovine serum albumin. 
     
     
         11 . A method of evaluating the binding characteristics of an anti- Pseudomonas aeruginosa  Psl antibody or antigen-binding fragment thereof to  Pseudomonas aeruginosa  Psl epitope, comprising
 (a) contacting the antibody with an oligosaccharide subunit of any one of  claims 1  to  10  under conditions that allow the antibody to bind the oligosaccharide subunit; and   (b) detecting the presence of a complex of the antibody and the oligosaccharide subunit.   
     
     
         12 . The method of  claim 11 , wherein the complex is detect by an ELISA assay. 
     
     
         13 . The method of  claim 11  or  claim 12 , further comprising:
 (c) classifying the antibody as binding to a class II epitope if it binds to each of the tetrasaccharide, pentasaccharide, hexasaccharide, and decasaccharide of  claim 5 ; and 
 (d) classifying the antibody as binding to a class III epitope if it binds to the hexasaccharide or decasaccharide of  claim 5 , but does not bind to the tetrasaccharide or the pentasaccharide of  claim 5 . 
 
     
     
         14 . A method of screening for antibodies which bind to  Pseudomonas aeruginosa  Psl, comprising:
 (a) contacting an antibody or antibody fragment library with an oligosaccharide subunit of any one of  claims 1  to  10  under conditions that allow Psl-specific antibodies or fragments thereof to bind the oligosaccharide subunit;   (b) detecting the presence of a complex of the antibody and the oligosaccharide subunit; and   (c) selecting antibodies which bind to the oligosaccharide subunit.   
     
     
         15 . The method of  claim 14 , wherein the complex is detect by an ELISA assay. 
     
     
         16 . A composition comprising the oligosaccharide subunit of any one of  claims 1  to  10 .

Join the waitlist — get patent alerts

Track US2016115250A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.